Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compliance of Once-daily vs Twice-daily Glimepiride/Metformin
NCT01444248Phase 4Completed
- Sponsor
- Handok
- Start
- Aug 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glimepiride + metformin in type 2 diabetes mellitus (T2DM), sponsored by Handok. Started Aug 2010; status: completed.
02
Drugs
glimepiride + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01444248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444248.